Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | COVID-19 and CLL

Lydia Scarfò • 2 Jun 2020
EHA 2020
Chronic Lymphocytic Leukemia Leukemia

Lydia Scarfò, MD, Vita-Salute San Raffaele University & IRCCS San Raffaele Scientific Institute, Milan, Italy, discusses the relationship between COVID-19 and chronic lymphocytic leukemia (CLL) patients. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Lydia Scarfò

1:56
Defining success in CLL
Lydia Scarfò • 8 Oct 2023
2:00
Prevention of TLS with venetoclax-based regimens
Lydia Scarfò • 8 Oct 2023
1:28
Challenges with defining fitness in CLL & important comorbidities to consider when selecting therapy
Lydia Scarfò • 8 Oct 2023
2:08
Choosing between continuous versus fixed-duration therapy in CLL
Lydia Scarfò • 8 Oct 2023

Related Videos

1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
3:21
Integrating genomics and MRD in transplant decision-making for patients with AML
Jurjen Versluis • 22 Apr 2024
4:19
Blinatumomab to achieve remission and consolidation with haploSCT for pediatric ALL
Alberto Olaya-Vargas • 15 Apr 2024
3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals